Skip to Main Content

Paper Details

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
Br J Haematol
4
2022
CALCA, GVHD, JAK1, Janus kinase 1, Monocyte-chemotactic protein (MCP)3, Plasma, ProCALCA, acute GVHD, acute graft-versus-host disease, calcitonin, graft-versus-host disease, itacitinib, participants, patients, pro-calcitonin, regenerating islet-derived protein (REG)3A, suppressor of tumorigenicity (ST)2, tumour necrosis factor receptor (TNFR)1
Author NameAffiliation
Sophie PaczesnyHollings Cancer Center
Sophie PaczesnyHollings Cancer Center
  • 1 - 2

Datasets

Release 1.2